Correction to: Progression of whole-blood transcriptional signatures from interferon-induced to neutrophil-associated patterns in severe influenza (Nature Immunology, (2018), 19, 6, (625-635), 10.1038/s41590-018-0111-5);Progression of whole-blood transcriptional signatures from interferon-induced to neutrophil-associated patterns in severe influenza

Nature Immunology

Volumn 19, Issue 6, 2018, Pages 625-635

  Dunning, Jake ^a,e   Blankley, Simon ^b   Hoang, Long T ^a   Cox, Mike ^a   Graham, Christine M ^b   James, Philip L ^a   Bloom, Chloe I ^b   Chaussabel, Damien ^c   Banchereau, Jacques ^d   Brett, Stephen J ^a   Habibi, Maximillian S ^a   Johnston, Sebastian L ^a   Hansel, Trevor T ^a   Levin, Mike ^a   Thwaites, Ryan S ^a   Warner, John O ^a   Cookson, William O ^a   Gazzard, Brian G ^f   Hay, Alan ^b   McCauley, John ^b   Aylin, Paul ^g   Ashby, Deborah ^g   Barclay, Wendy S ^g   Elderfield, Ruth A ^g   Nadel, Simon ^g,h   Herberg, Jethro A ^g   Drumright, Lydia N ^g   Garcia Alvarez, Laura ^g   Holmes, Alison H ^g   Kon, Onn M ^a,h   Aston, Stephen J ⁱ   Gordon, Stephen B ⁱ   Hussell, Tracy ^j   Thompson, Catherine ^e   Zambon, Maria C ^e   Baillie, Kenneth J ^k   Hume, David A ^k   Simmonds, Peter ^k   Hayward, Andrew ^l   Smyth, Rosalind L ^m   McNamara, Paul S ⁿ   Semple, Malcolm G ⁿ   Nguyen Van Tam, Jonathan S ^o   Ho, Ling Pei ^p   McMichael, Andrew J ^p   Kellam, Paul ^q   Adamson, Walt E ^r   Carman, William F ^r   Griffiths, Mark J ^s   Moffatt, Miriam F ^a   O'Garra, Anne ^b   Openshaw, Peter J M ^a   more..

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b THE FRANCIS CRICK INSTITUTE   (United Kingdom)

^c SIDRA MEDICAL AND RESEARCH CENTER   (Qatar)

^d JACKSON LABORATORY   (United States)

^e PUBLIC HEALTH ENGLAND   (United Kingdom)

^f CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^g IMPERIAL COLLEGE LONDON   (United Kingdom)

^h IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

ⁱ LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^j Manchester Academic Health Science Centre   (United Kingdom)

^k UNIVERSITY OF EDINBURGH   (United Kingdom)

^l UNIVERSITY COLLEGE LONDON   (United Kingdom)

^m UNIVERSITY COLLEGE LONDON   (United Kingdom)

ⁿ UNIVERSITY OF LIVERPOOL   (United Kingdom)

^o UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^p UNIVERSITY OF OXFORD   (United Kingdom)

^q WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^r West of Scotland Specialist Virology Laboratory Gartnavel   (United Kingdom)

^s ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; BIOLOGICAL MARKER; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTOME;

ADOLESCENT; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL INFECTION; CELL DEATH; CELL STRESS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; INFLAMMATION; INFLUENZA; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTOMICS; UPREGULATION; VIRUS LOAD; BLOOD; DISEASE EXACERBATION; GENETICS; IMMUNOLOGY; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOMARKERS; DISEASE PROGRESSION; FEMALE; HUMANS; INFLUENZA, HUMAN; INTERFERONS; MALE; MIDDLE AGED; NEUTROPHILS; RNA, MESSENGER; TRANSCRIPTOME; YOUNG ADULT;

EID: 85047165324     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/s41590-019-0328-y     Document Type: Erratum

References (43)

1. Stöhr, K. Preventing and treating influenza. Br. Med. J. 326, 1223-1224 (2003).
2. Hayward, A. C. et al. Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study. Lancet Respir. Med. 2, 445-454 (2014).
3. Dawood, F. S. et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect. Dis. 12, 687-695 (2012).
4. Bautista, E. et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N. Engl. J. Med. 362, 1708-1719 (2010).
5. Hui, D. S., Lee, N. & Chan, P. K. Clinical management of pandemic 2009 influenza A(H1N1) infection. Chest 137, 916-925 (2010).
6. Peiris, J. S., Cheung, C. Y., Leung, C. Y. & Nicholls, J. M. Innate immune responses to influenza A H5N1: friend or foe? Trends Immunol. 30, 574-584 (2009).
7. Tisoncik, J. R. et al. Into the eye of the cytokine storm. Microbiol. Mol. Biol. Rev. 76, 16-32 (2012).
8. de Jong, M. D. et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12, 1203-1207 (2006).
9. Ioannidis, I. et al. Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection. J. Virol. 86, 5422-5436 (2012).
10. Ramilo, O. et al. Gene expression patterns in blood leukocytes discriminate patients with acute infections. Blood 109, 2066-2077 (2007).
11. Zaas, A. K. et al. Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. Cell Host Microbe 6, 207-217 (2009).
12. Woods, C. W. et al. A host transcriptional signature for presymptomatic detection of infection in humans exposed to influenza H1N1 or H3N2. PLoS One 8, e52198 (2013).
13. Nakaya, H. I. et al. Systems biology of vaccination for seasonal influenza in humans. Nat. Immunol. 12, 786-795 (2011).
14. Li, S. et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat. Immunol. 15, 195-204 (2014).
15. Obermoser, G. et al. Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. Immunity 38, 831-844 (2013).
16. Blankley, S. et al. The application of transcriptional blood signatures to enhance our understanding of the host response to infection: the example of tuberculosis. Phil. Trans. R. Soc. Lond. B 369, 20130427 (2014).
17. Pascual, V., Chaussabel, D. & Banchereau, J. A genomic approach to human autoimmune diseases. Annu. Rev. Immunol. 28, 535-571 (2010).
18. Everitt, A. R. et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484, 519-523 (2012).
19. Ruggiero, T. et al. A(H1N1)pdm09 hemagglutinin D222G and D222N variants are frequently harbored by patients requiring extracorporeal membrane oxygenation and advanced respiratory assistance for severe A(H1N1)pdm09 infection. Influenza Other Respir. Viruses 7, 1416-1426 (2013).
20. Rykkvin, R., Kilander, A., Dudman, S.G. & Hungnes, O. Within-patient emergence of the influenza A(H1N1)pdm09 HA1 222G variant and clear association with severe disease, Norway. Euro Surveill. 18, 20369 (2013).
21. Herfst, S. et al. Introduction of virulence markers in PB2 of pandemic swine-origin influenza virus does not result in enhanced virulence or transmission. J. Virol. 84, 3752-3758 (2010).
22. Elderfield, R. A. et al. Accumulation of human-adapting mutations during circulation of A(H1N1)pdm09 influenza virus in humans in the United Kingdom. J. Virol. 88, 13269-13283 (2014).
23. Chaussabel, D. et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 29, 150-164 (2008).
24. Pankla, R. et al. Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis. Genome Biol. 10, R127 (2009).
25. Simon, L., Gauvin, F., Amre, D. K., Saint-Louis, P. & Lacroix, J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin. Infect. Dis. 39, 206-217 (2004).
26. Wu, M. H. et al. Can procalcitonin tests aid in identifying bacterial infections associated with influenza pneumonia? A systematic review and meta-analysis. Influenza Other Respir. Viruses 7, 349-355 (2013).
27. Falsey, A. R. et al. Bacterial complications of respiratory tract viral illness: a comprehensive evaluation. J. Infect. Dis. 208, 432-441 (2013).
28. McNab, F., Mayer-Barber, K., Sher, A., Wack, A. & O'Garra, A. Type I interferons in infectious disease. Nat. Rev. Immunol. 15, 87-103 (2015).
29. Marshall, J. C. Iatrogenesis, inflammation and organ injury: insights from a murine model. Crit. Care 10, 173 (2006).
30. Openshaw, P. J. & Chiu, C. Protective and dysregulated T cell immunity in RSVinfection. Curr. Opin. Virol. 3, 468-474 (2013).
31. Davidson, S., Crotta, S., McCabe, T. M. & Wack, A. Pathogenic potential of interferon alphabeta in acute influenza infection. Nat. Commun. 5, 3864 (2014).
32. Gregory, D. J. & Kobzik, L. Influenza lung injury: mechanisms and therapeutic opportunities. Am. J. Physiol. Lung Cell. Mol. Physiol. 309, L1041-L1046 (2015).
33. Short, K. R., Kroeze, E. J. B. V., Fouchier, R. A. M. & Kuiken, T. Pathogenesis of influenza-induced acute respiratory distress syndrome. Lancet Infect. Dis. 14, 57-69 (2014).
34. Sandler, N. G. et al. Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression. Nature 511, 601-605 (2014).
35. Biron, C. A. Interferons alpha and beta as immune regulators-a new look. Immunity 14, 661-664 (2001).
36. Narasaraju, T. et al. Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am. J. Pathol. 179, 199-210 (2011).
37. + T-cell activation during natural respiratory syncytial virus infection in infants. J. Virol. 84, 2374-2383 (2010).
38. + T-cell responses in the respiratory tract following influenza infection. Immunol. Cell Biol. 90, 197-205 (2012).
39. + T cells in the airways. Science 349, aaa4352 (2015).
40. Mayer-Barber, K. D. et al. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature 511, 99-103 (2014).
41. Carr, M. J. et al. Development of a real-time RT-PCR for the detection of swine-lineage influenza A (H1N1) virus infections. J. Clin. Virol. 45, 196-199 (2009).
42. Nguyen-Van-Tam, J. S. et al. Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009). Thorax 65, 645-651 (2010).
43. Ashburner, M. et al. The Gene Ontology Consortium. Gene ontology: tool for the unification of biology. Nat. Genet. 25, 25-29 (2000).